A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00597649
Recruitment Status : Terminated (The 001 trial did not show benefit versus placebo)
First Posted : January 18, 2008
Last Update Posted : June 30, 2009
Information provided by:
XTL Biopharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : December 2008